Regulators of Photoreceptor Aerobic Glycolysis in Retinal Health and Disease
Regulators of Photoreceptor Aerobic Glycolysis in Retinal Health and Disease
批准号:
10717825
负责人:
Raju VS Rajala
金额:
$42.93万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-01 至 2027-06-30
关键词:
AblationAffectAffinity ChromatographyAge related macular degenerationAgingAldehyde-LyasesAldolase CAmericanAnabolismAntibodiesAntioxidantsCell physiologyCellsComplexDNADiseaseEnzymesGene ExpressionGene Expression ProfileGlucoseGlycolysisGoalsHealthIn VitroInterphase CellKnockout MiceKnowledgeLabelLightLipidsMediatingMediatorMessenger RNAMetabolicMetabolismMissionMolecularMusNational Eye InstituteOutcomePathogenesisPathogenicityPathologicPathologyPatientsPhosphoenolpyruvatePhosphorylationPhotoreceptorsProcessProtein DephosphorylationProtein Tyrosine KinaseProteinsPublicationsPyruvatePyruvate KinaseRNARegulationRetinaRetinal DegenerationRhodopsinRibosomesRodRoleSignal TransductionStructureStructure of retinal pigment epitheliumTechniquesTestingTranscription CoactivatorTranslatingTyrosine PhosphorylationUnited States National Institutes of HealthVisionWarburg EffectWorkaerobic glycolysisageddesignexperimental studyinnovationknock-downlipid biosynthesismouse modelnormoxianovelnovel therapeuticspreventprotein tyrosine phosphatase 1Bretinal rodssrc-Family Kinasestumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
The Warburg Effect (WE) is the enhanced anaerobic conversion of glucose to lactate observed in tumor and
retinal cells, even in normoxia. Both tumor and retinal cells repurpose glucose for anabolic biosynthesis of lipid,
protein, RNA/DNA, and antioxidant molecules. In the retina, dysregulation of anabolic processes is associated
with age-related macular degeneration (AMD), which afflicts 15 million Americans with devastating effects on
their vision. Anabolic processes are regulated by the glycolytic enzymes pyruvate kinase M2 (PKM2) and
aldolase. Aldolase promotes anabolism by regulating PKM2 activity (conversion of phosphoenolpyruvate [PEP]
to pyruvate [Pyr]), which is controlled by its phosphorylation status. Furthermore, anti-PKM2 and anti-ALDOC
antibodies have been identified in AMD patient retinas, implicating their involvement in anabolic dysregulation
in AMD pathogenesis. Thus, understanding the interplay between PKM2 and ALDOC - two key mediators of
the WE - will help elucidate the mechanisms by which anabolic processes are regulated in healthy retinas and
how they are dysregulated in pathogenic conditions.
Our preliminary studies show that non-receptor tyrosine kinase Src phosphorylates PKM2 in vitro. Our earlier
studies show that in the retina Src activation and PTP1B activity inhibition are light- and rhodopsin-dependent.
We will test the hypothesis that cSrc and PTP1B regulate PKM2 phosphorylation, thereby determining the
mechanism of light- and rhodopsin-dependent regulation of anabolism in photoreceptor (PR) cells (Aim 1). In
Aim 2, we will test the hypothesis that ALDOC affects PKM2 in diverse ways in the PR and retinal pigment
epithelial (RPE) cells, thereby determining the regulatory role of ALDOC in RPE and PR cells. Aim 3 will test
the hypothesis that retinal aging and AMD are accompanied by a PKM2-dependent dynamic change in actively
translated mRNA repertoire, thereby elucidating the role of PKM2 in regulating PR and RPE gene expression
The outcome of this project will be a deeper understanding of how mediators of the WE regulate retina
structure, functions, and viability. This knowledge is fundamentally important for understanding how PR and
RPE cells function and stay alive in normal and pathologic conditions, and are directly relevant to the mission
of the National Eye Institute, NIH. Successful completion of these studies will pave the path for developing
strategies to prevent/delay retinal degeneration.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neuroprotection Mechanism for Photoreceptors
-
批准号:10428577
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2019
-
负责人:Raju VS Rajala
-
依托单位:
Neuroprotection Mechanism for Photoreceptors
-
批准号:10183260
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2019
-
负责人:Raju VS Rajala
-
依托单位:
Neuroprotection Mechanism for Photoreceptors
-
批准号:10006824
-
项目类别:
-
资助金额:$42.27万
-
财政年份:2019
-
负责人:Raju VS Rajala
-
依托单位:
Mechanistic studies on obesity-deteriorated glucose and lipid metabolisms
-
批准号:8874215
-
项目类别:
-
资助金额:$32.19万
-
财政年份:2013
-
负责人:Raju VS Rajala
-
依托单位:
P30 Center Core Grant for Vision Research
-
批准号:10272005
-
项目类别:
-
资助金额:$29.49万
-
财政年份:2011
-
负责人:Raju VS Rajala
-
依托单位:
P30 Center Core Grant for Vision Research
-
批准号:10477417
-
项目类别:
-
资助金额:$29.49万
-
财政年份:2011
-
负责人:Raju VS Rajala
-
依托单位:
P30 Center Core Grant for Vision Research
-
批准号:10696213
-
项目类别:
-
资助金额:$29.49万
-
财政年份:2011
-
负责人:Raju VS Rajala
-
依托单位:
COBRE: INSULIN RECEPTOR SIGNALING IN DIABETIC RETINOPATHY
-
批准号:7720534
-
项目类别:
-
资助金额:$21.5万
-
财政年份:2008
-
负责人:Raju VS Rajala
-
依托单位:
COBRE: INSULIN RECEPTOR SIGNALING IN DIABETIC RETINOPATHY
-
批准号:7610500
-
项目类别:
-
资助金额:$7.26万
-
财政年份:2007
-
负责人:Raju VS Rajala
-
依托单位:
COBRE: INSULIN RECEPTOR SIGNALING IN RETINA
-
批准号:7381939
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2006
-
负责人:Raju VS Rajala
-
依托单位:
Light Activation of Retinal Insulin Receptor Signaling
-
批准号:8526462
-
项目类别:
-
资助金额:$33.74万
-
财政年份:2006
-
负责人:Raju VS Rajala
-
依托单位:
Light Activation of Retinal Insulin Receptor Signaling
-
批准号:7257011
-
项目类别:
-
资助金额:$32.01万
-
财政年份:2006
-
负责人:Raju VS Rajala
-
依托单位:
Light Activation of Retinal Insulin Receptor Signaling
-
批准号:7145574
-
项目类别:
-
资助金额:$32.96万
-
财政年份:2006
-
负责人:Raju VS Rajala
-
依托单位:
Light Activation of Retinal Insulin Receptor Signaling
-
批准号:8323409
-
项目类别:
-
资助金额:$35.52万
-
财政年份:2006
-
负责人:Raju VS Rajala
-
依托单位:
Light Activation of Retinal Insulin Receptor Signaling
-
批准号:7985004
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2006
-
负责人:Raju VS Rajala
-
依托单位:
Light Activation of Retinal Insulin Receptor Signaling
-
批准号:8128492
-
项目类别:
-
资助金额:$35.52万
-
财政年份:2006
-
负责人:Raju VS Rajala
-
依托单位:
Light Activation of Retinal Insulin Receptor Signaling
-
批准号:7633165
-
项目类别:
-
资助金额:$32.01万
-
财政年份:2006
-
负责人:Raju VS Rajala
-
依托单位:
Light Activation of Retinal Insulin Receptor Signaling
-
批准号:7442117
-
项目类别:
-
资助金额:$31.37万
-
财政年份:2006
-
负责人:Raju VS Rajala
-
依托单位:
COBRE: INSULIN RECEPTOR SIGNALING IN RETINA
-
批准号:7171159
-
项目类别:
-
资助金额:$16.93万
-
财政年份:2005
-
负责人:Raju VS Rajala
-
依托单位:
COBRE: INSULIN RECEPTOR SIGNALING IN RETINA
-
批准号:6982236
-
项目类别:
-
资助金额:$23.0万
-
财政年份:2004
-
负责人:Raju VS Rajala
-
依托单位:
海外基金